REPORT ID 6818

Global Kidney Fibrosis Treatment Market Size, Status and Forecast 2022

Publish Date
1-Nov-17
Pages
90
Format
Electronic (PDF)

This report studies the global Kidney Fibrosis Treatment market, analyzes and researches the Kidney Fibrosis Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Merck & Co
    F. Hoffman-La Roche Ltd
    Pfizer
    Galectin Therapeutics
    La Jolla Pharmaceutical Company
    InterMune
    ProMetic Life-Sciences
    Genzyme Corporation
    BioLine Rx Ltd

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, Kidney Fibrosis Treatment can be split into
    Angiotensin II receptor blockers (ARBs)
    Angiotensin Converting Enzyme (ACE) inhibitors
    Pirfenidone
    Renin Inhibitors
    Vasopeptidase Inhibitors

Market segment by Application, Kidney Fibrosis Treatment can be split into
    Hospital testing
    Clinics
    Home Treatment

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Kidney Fibrosis Treatment Market Size, Status and Forecast 2022
1 Industry Overview of Kidney Fibrosis Treatment
    1.1  Kidney Fibrosis Treatment Market Overview
        1.1.1 Kidney Fibrosis Treatment Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Kidney Fibrosis Treatment Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Kidney Fibrosis Treatment Market by Type
        1.3.1 Angiotensin II receptor blockers (ARBs)
        1.3.2 Angiotensin Converting Enzyme (ACE) inhibitors
        1.3.3 Pirfenidone
        1.3.4 Renin Inhibitors
        1.3.5 Vasopeptidase Inhibitors
    1.4 Kidney Fibrosis Treatment Market by End Users/Application
        1.4.1 Hospital testing
        1.4.2 Clinics
        1.4.3 Home Treatment

2 Global Kidney Fibrosis Treatment Competition Analysis by Players
    2.1 Kidney Fibrosis Treatment Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Merck & Co
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 F. Hoffman-La Roche Ltd
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Pfizer
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Galectin Therapeutics
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 La Jolla Pharmaceutical Company
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 InterMune
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 ProMetic Life-Sciences
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Genzyme Corporation
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 BioLine Rx Ltd
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Kidney Fibrosis Treatment Revenue (Value) (2012-2017)
        3.9.5 Recent Developments

4 Global Kidney Fibrosis Treatment Market Size by Type and Application (2012-2017)
    4.1 Global Kidney Fibrosis Treatment Market Size by Type (2012-2017)
    4.2 Global Kidney Fibrosis Treatment Market Size by Application (2012-2017)
    4.3 Potential Application of Kidney Fibrosis Treatment in Future
    4.4 Top Consumer/End Users of Kidney Fibrosis Treatment

5 United States Kidney Fibrosis Treatment Development Status and Outlook
    5.1 United States Kidney Fibrosis Treatment Market Size (2012-2017)
    5.2 United States Kidney Fibrosis Treatment Market Size and Market Share by Players (2016 and 2017)

6 EU Kidney Fibrosis Treatment Development Status and Outlook
    6.1 EU Kidney Fibrosis Treatment Market Size (2012-2017)
    6.2 EU Kidney Fibrosis Treatment Market Size and Market Share by Players (2016 and 2017)

7 Japan Kidney Fibrosis Treatment Development Status and Outlook
    7.1 Japan Kidney Fibrosis Treatment Market Size (2012-2017)
    7.2 Japan Kidney Fibrosis Treatment Market Size and Market Share by Players (2016 and 2017)

8 China Kidney Fibrosis Treatment Development Status and Outlook
    8.1 China Kidney Fibrosis Treatment Market Size (2012-2017)
    8.2 China Kidney Fibrosis Treatment Market Size and Market Share by Players (2016 and 2017)

9 India Kidney Fibrosis Treatment Development Status and Outlook
    9.1 India Kidney Fibrosis Treatment Market Size (2012-2017)
    9.2 India Kidney Fibrosis Treatment Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Kidney Fibrosis Treatment Development Status and Outlook
    10.1 Southeast Asia Kidney Fibrosis Treatment Market Size (2012-2017)
    10.2 Southeast Asia Kidney Fibrosis Treatment Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Kidney Fibrosis Treatment Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Kidney Fibrosis Treatment Revenue and Growth Rate (2017-2022)
        11.1.2 EU Kidney Fibrosis Treatment Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Kidney Fibrosis Treatment Revenue and Growth Rate (2017-2022)
        11.1.4 China Kidney Fibrosis Treatment Revenue and Growth Rate (2017-2022)
        11.1.5 India Kidney Fibrosis Treatment Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Kidney Fibrosis Treatment Revenue and Growth Rate (2017-2022)
    11.2 Global Kidney Fibrosis Treatment Market Size (Value) by Type (2017-2022)
    11.3 Global Kidney Fibrosis Treatment Market Size by Application (2017-2022)

12 Kidney Fibrosis Treatment Market Dynamics
    12.1 Kidney Fibrosis Treatment Market Opportunities
    12.2 Kidney Fibrosis Treatment Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Kidney Fibrosis Treatment Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Kidney Fibrosis Treatment Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source